Skip to main content

Animations

MJFF Publications

1601 - 1610 of 6451 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2023
  • 2021
  • 2021
  • 2022
  • 2020
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022
    Journal Name: Pharmacoepidemiology and Drug Safety
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pds.5518
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Spatially informed Bayesian neural network for neurodegenerative diseases classification
    Journal Name: Statistics in Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/sim.9604
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer’s disease, restores synapse integrity and memory in a disease mouse model
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.89453
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study
    Journal Name: Journal of the American Psychiatric Nurses Association
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/10783903211023565
    Citation Count: 17
  • Summary Details
    OPEN
    Title: ECTRIMS 2021 – Late Breaking News ePoster
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/13524585211047080
    Citation Count: 4
  • ECTRIMS 2022 – Poster
    2022
    Summary Details
    OPEN
    Title: ECTRIMS 2022 – Poster
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/13524585221123687
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition
    Journal Name: Molecular Cancer Therapeutics
    Publisher: American Association for Cancer Research (AACR)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Programming Directional Deep Brain Stimulation in Parkinson’s Disease: A Randomized Prospective Trial Comparing Early versus Delayed Stimulation Steering
    Journal Name: Stereotactic and Functional Neurosurgery
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000517054
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
    Journal Name: European Neurology
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000517538
    Citation Count: 7
  • Summary Details
    OPEN
    Title: A comparative and comprehensive study of prediction of Parkinson’s disease
    Journal Name: Indonesian Journal of Electrical Engineering and Computer Science
    Publisher: Institute of Advanced Engineering and Science
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.11591/ijeecs.v23.i3.pp1748-1760
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.